A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on messaging platforms, based on new investigations.
Investigational Treatment Gaining Traction Online
Retatrutide, which is still in research studies, is being advertised by social media influencers for its alleged fat-burning effects. Viewers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.
Thriving Commerce on Messaging Platforms
Additionally, a robust market exists on Telegram, where groups with thousands of participants share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the drug there before directing buyers to WhatsApp for purchases.
Understanding Retatrutide
This medication is an experimental injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Express Concerns
However, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the United Kingdom is worrisome and could result in individuals injecting products of unknown origin.
Several experts said the demand for retatrutide could be linked to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Position and Enforcement
Marketing retatrutide on TikTok or Telegram is illegal in the UK, as it is an unapproved drug that cannot be promoted or distributed for human use under the British medical regulations.
Several content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but promotion and distribution can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.
Service Response and Material Removal
According to the social media company, the service has taken down problematic material and prohibited associated hashtags and search suggestions. The organization said it was dedicated to keeping the platform secure and allocating resources in strengthening compliance measures.
Online Marketplace Activities
Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, filled with images of weight loss, positive reviews and detailed guides for preparing or administering at home.
Within moments of entering one community, a vendor shared WhatsApp details, where most purchases take place. The seller provided an instruction manual and promised delivery within 48 hours. When questioned whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. None inquired about body mass, health issues or previous experience.
Product Information and Pricing
Inside these communities, messages show black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting answers ranging from a several days to “depends on your body”.
Platform Moderation and Security Measures
A spokesperson for Telegram stated it actively moderated harmful material on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“People are administering materials they cannot confirm. Even if the research behind retatrutide is valid, these online versions may not include what they advertise,” stated a pharmacy expert, the head of pharmacy at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to current cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were produced in was sterile,” she explained.
Her team has previously encountered individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly stated the substance was in third stage research studies and had not been evaluated or approved by any regulatory agency globally. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially significant medical dangers”.
